Skip to content

Salicylamide

NERVOUS SYSTEM

Also known as: 2-carbamoylphenol, 2-hydroxybenzamide, salicylic acid amide

FDA approvedATC N02BA05ATC N02BA55ATC N02BA75

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Salicylamide is a drug catalogued in DrugCentral. Recorded indications include Backache, Fever, Headache disorder and Joint pain.

  • Indications: Backache, Fever, Headache disorder, Joint pain and Pain.
  • ATC code: N02BA05 (Salicylic acid and derivatives).
  • Molecular formula: C7H7NO2; molecular weight 137.14 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (5)

  • Backache
  • Fever
  • Headache disorder
  • Joint pain
  • Pain

Contraindications (86)

  • Acute abdominal pain
  • Acute erosive gastritis
  • Acute exacerbation of asthma
  • Acute nephropathy
  • Agoraphobia
  • Alcoholism
  • Aluminum intoxication
  • Anemia
  • Anemia due to enzyme deficiency
  • Angle-closure glaucoma
  • Atrophic gastritis
  • Benign intracranial hypertension
  • Benign prostatic hyperplasia
  • Bladder outflow obstruction
  • Blood coagulation disorder
  • Body fluid retention
  • Bradycardia
  • Breastfeeding (mother)
  • Cardiovascular event risk
  • Central nervous system depression
  • Chronic diarrhea
  • Chronic disease of respiratory system
  • Chronic idiopathic constipation
  • Chronic obstructive lung disease
  • Conduction disorder of the heart
  • Constipation
  • Decreased respiratory function
  • Dependent drug abuse
  • Diabetes mellitus
  • Disease of liver
  • + 56 more

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
—FDA——

ATC classification

ATC codeTherapeutic hierarchy
N02BA05NERVOUS SYSTEM › ANALGESICS › OTHER ANALGESICS AND ANTIPYRETICS › Salicylic acid and derivatives
N02BA55NERVOUS SYSTEM › ANALGESICS › OTHER ANALGESICS AND ANTIPYRETICS › Salicylic acid and derivatives
N02BA75NERVOUS SYSTEM › ANALGESICS › OTHER ANALGESICS AND ANTIPYRETICS › Salicylic acid and derivatives

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Sedation complication356.0
Creatinine renal clearance decreased348.2
Blood calcium decreased300.9
Renal function test abnormal287.6
Creatinine renal clearance increased273.6
Orthostatic hypotension259.7
Sedation253.1

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Salicylamide is on its molecule page.

Molecular formulaC7H7NO2
Molecular weight137.14 g/mol
CAS number65-45-2
InChIKeySKZKKFZAGNVIMN-UHFFFAOYSA-N
PubChem CID5147
NC(=O)C1=CC=CC=C1O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Salicylamide used for?

DrugCentral lists the following indications for Salicylamide: Backache, Fever, Headache disorder, Joint pain and Pain.

What is the chemical formula of Salicylamide?

Salicylamide has the molecular formula C7H7NO2 and a molecular weight of 137.14 g/mol.

Browse: all drugs starting with S · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
AgencyFDA
Targets0
Indications5
FormulaC7H7NO2
DrugCentral ID2415
Interactive profile